GTBIFOTCAgricultural Production-CropsUS GAAP · USD

Green Thumb Industries Inc.

Green Thumb Industries Inc. is a U.S.-based cannabis company that grows, processes, manufactures, distributes, and sells cannabis products through both branded consumer packaged goods and its own retail dispensaries. Founded in 2014 and headquartered in Chicago, it operates across 14 U.S. markets and combines cultivation, manufacturing, wholesale distribution, and retail under the RISE Dispensaries banner.

Liikevaihto1 175milj. USD
+3,4 %v/v
Liikevoitto (EBIT)138milj. USD
−38,6 %v/v
EBIT-marginaali11,7%
−8,0 %-yks.v/v
Nettotulos114milj. USD
+56,2 %v/v
Vapaa kassavirta214milj. USD
+86,0 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

02505007501 0001 250milj. USD2020: 557 milj. USD2020: EBIT 106 milj. USD20202021: 894 milj. USD2021: EBIT 215 milj. USD20212022: 1 017 milj. USD2022: EBIT 121 milj. USD20222023: 1 055 milj. USD2023: EBIT 185 milj. USD20232024: 1 137 milj. USD2024: EBIT 224 milj. USD20242025: 1 175 milj. USD2025: EBIT 138 milj. USD20251 175138
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Retail cannabis sales71 %

Sales of cannabis-related products through owned dispensaries, primarily under the RISE brand.

Consumer Packaged Goods29 %

Branded cannabis products manufactured, distributed, and sold to third-party licensed retailers and company stores.

Asiakkaat

Green Thumb sells to two main customer groups: consumers and patients who shop its owned dispensaries, and licensed cannabis retailers that buy its branded products for resale. The company also serves adult-use and medical markets across its operating states, with demand shaped by local licensing, product availability, and state regulations.

Retail dispensary consumers and patients

Buy cannabis-related products at RISE and other stores for personal use, wellness, or medical needs.

Licensed third-party cannabis retailers

Purchase Green Thumb-branded products for resale in state-licensed dispensaries.

Adult-use market customers

Buy products in states where recreational cannabis is legal, supporting store traffic and basket growth.

Medical cannabis patients

Purchase regulated cannabis products for therapeutic use in medical programs.

Strategia

Green Thumb’s strategy centers on combining owned retail with branded product manufacturing to capture value across the cannabis supply chain. Management is focused on sustainable profitable growth, expanding within existing markets, and adding stores or partnerships when licensing and capital conditions allow.

Expand retail footprint in existing marketsLyhyt aikaväli

More stores increase direct-to-consumer reach and improve control over merchandising and margins.

Scale branded products through wholesale and retail channelsKeskipitkä aikaväli

Branded products create repeat demand and diversify revenue beyond store traffic.

Maintain sustainable profitable growthKeskipitkä aikaväli

Cannabis markets remain competitive and regulated, so disciplined growth is needed to protect returns.

Maantiede

Green Thumb operates in 14 U.S. states, with revenue generated across California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, and Virginia. Its manufacturing footprint spans 13 states, while RISE dispensaries are present in all 14 markets, making state-level licensing and local regulation central to growth and operating flexibility.

Riskit

Green Thumb faces regulatory, competitive, and operating risks typical of the cannabis industry, including state-by-state licensing constraints, unfavorable U.S. tax treatment, and competition from lower-priced unregulated products. Its vertically integrated model also exposes it to cultivation, product quality, and retail execution risks, while the company’s early-stage industry context and concentrated voting control add governance and execution uncertainty.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Unfavorable tax treatment1Competition from unregulated products2Regulatory and licensing constraints3Agricultural and cultivation risk4Product liability and recalls5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Unfavorable tax treatmentVaikutus: KorkeaTodennäköisyys: Korkea

    Cannabis businesses may face significant tax burdens that compress margins and cash flow.

    Kohdistuu: After-tax earnings and liquidity

  2. Competition from unregulated productsVaikutus: KorkeaTodennäköisyys: Korkea

    Untaxed or untested products can be priced lower than regulated cannabis.

    Kohdistuu: Pricing power and market share

  3. Regulatory and licensing constraintsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Cannabis operations depend on state approvals, local permissions, and changing rules.

    KohdistuuStore openingsMarket entryOperating continuity
  4. Agricultural and cultivation riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    The company grows cannabis, so pests, disease, climate control failures, and yield variability can affect supply.

    Kohdistuu: Production volumes and cost of goods sold

  5. Product liability and recallsVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Cannabis products can trigger claims if quality, labeling, or safety issues arise.

    KohdistuuBrand reputationLegal costsSales

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Sales occur through retail stores and wholesale channels, so timing differs by transaction type.

Vaikutus: Affects reported revenue timing and comparability across periods

Inventory costing and overhead allocation

Cultivation, processing, packaging, and allocated facility costs flow into cost of goods sold.

Vaikutus: Affects gross profit and margin volatility

Goodwill impairment

Valuation depends on future cash flows, discount rates, and market conditions in a volatile industry.

Vaikutus: Can create large non-cash charges

Lease accounting

Dispensaries, cultivation sites, and manufacturing facilities are lease-intensive.

Vaikutus: Affects balance sheet leverage and operating expense presentation

Brand intellectual property sale and licensing

The 2025 sale of CPG brand IP and exclusive licensing requires judgment on gains and ongoing economics.

Vaikutus: Affects other income, intangible assets, and future royalty/license expense

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026

Green Thumb Industries Inc. (OTC) – Agricultural Production-Crops | Analyysi – Clarifo